Anuradha Banerjee MD

tl_files/NS_Main/Faculty/Banerjee.jpg

Associate Clinical Professor of Pediatrics and Neurological Surgery

Pediatric Neuro-oncologist









Dr. Banerjee is a pediatrician with fellowship training in pediatric hematology and oncology. She is also an epidemiologist and has a special interest in pediatric palliative care. She currently works with Dr. Michael Prados in Pediatric Brain Tumor Consortium clinical trials. Dr. Banerjee's research at present involves the use of convection-enhanced delivery of novel drugs for treatment of high-grade glioma, and the role of signal transduction inhibitors with radiation for the treatment of brainstem glioma.

Pediatric Brain Tumor Center

Download the UCSF Pediatric Brain Tumor Center Brochure

 











Education, Training, and Previous Positions

1987: BA, Stanford University
1996: BA, Harvard University
1990: MPH, Tulane School of Public Health
1992: MD, Tulane School of Medicine
1992-1996: Residency in Pediatrics, UCSF
1999-2001: Assistant Clinical Professor of Pediatrics, UCSF
2001-Present: Department of Neurological Surgery, UCSF

Selected Professional Memberships and Appointments

American Association for Cancer Research
American Society of Clinical Oncology
Children's Oncology Group
Pediatric Brain Tumor Consortium
Society for Neuro-Oncology
The American Society of Pediatric Hematology/Oncology

Selected Recent Publications

Pejavar S, Polley MY, Rosenberg-Wohl S, Chennupati S, Prados MD, Berger MS, Banerjee A, Gupta N, Haas-Kogan D. Pediatric intracranial ependymoma: the roles of surgery, radiation and chemotherapy. J Neurooncol 2012;106(2):367-75.

Rauen KA, Banerjee A, Bishop WR, Lauchle JO, McCormick F, McMahon M, Melese T, Munster PN, Nadaf S, Packer RJ, Sebolt-Leopold J, Viskochil DH. Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies. Am J Med Genet C Semin Med Genet 2011;157(2):136-46.

Haas-Kogan DA, Banerjee A, Poussaint TY, Kocak M, Prados MD, Geyer JR, Fouladi M, Broniscer A, Minturn JE, Pollack IF, Packer RJ, Boyett JM, Kun LE. Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas. Neuro Oncol 2011;13(3):298-306.

Mishra KK, Squire S, Lamborn K, Banerjee A, Gupta N, Wara WM, Prados MD, Berger MS, Haas-Kogan DA. Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update. J Neurooncol 2010;100(1):121-7.

Nicolaides T, Tihan T, Horn B, Biegel J, Prados M, Banerjee A. High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system. J Neurooncol 2010;98(1):117-23.

Hashizume R, Ozawa T, Dinca EB, Banerjee A, Prados MD, James CD, Gupta N. A human brainstem glioma xenograft model enabled for bioluminescence imaging. J Neurooncol 2010;96(2):151-9.

McBride SM, Daganzo SM, Banerjee A, Gupta N, Lamborn KR, Prados MD, Berger MS, Wara WM, Haas-Kogan DA. Radiation is an Important Component of Multimodality Therapy for Pediatric Non-Pineal Supratentorial Primitive Neuroectodermal Tumors. Int J Radiat Oncol Biol Phys 2008;72(5):1319-23.

Haas-Kogan DA, Banerjee A, Kocak M, Prados MD, Geyer JR, Fouladi M, McKnight T, Poussaint TY, Broniscer A, Blaney SM, Boyett JM, Kun LE. Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma. Neuro Oncol 2008;10(3):341-7.

Pang J, Banerjee A, Tihan T. The value of tandem CSF/MRI evaluation for predicting disseminated disease in childhood central nervous system neoplasms. J Neurooncol 2008;87(1):97-102.

Kieran MW, Packer RJ, Onar A, Blaney SM, Phillips P, Pollack IF, Geyer JR, Gururangan S, Banerjee A, Goldman S, Turner CD, Belasco JB, Broniscer A, Zhu Y, Frank E, Kirschmeier P, Statkevich P, Yver A, Boyett JM, Kun LE. Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor Consortium Study. J Clin Oncol 2007;25(21):3137-43.

Pollack IF, Jakacki RI, Blaney SM, Hancock ML, Kieran MW, Phillips P, Kun LE, Friedman H, Packer R, Banerjee A, Geyer JR, Goldman S, Poussaint TY, Krasin MJ, Wang Y, Hayes M, Murgo A, Weiner S, Boyett JM. Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report. Neuro Oncol 2007;9(2):145-60.

Mishra KK, Puri DR, Missett BT, Lamborn KR, Prados MD, Berger MS, Banerjee A, Gupta N, Wara WM, Haas-Kogan DA. The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas. Neuro Oncol 2006;8(2):166-74.

Etzell JE, Keet C, McDonald W, Banerjee A. Medulloblastoma simulating acute myeloid leukemia: case report with a review of "myeloid antigen" expression in nonhematopoietic tissues and tumors [Review]. J Pediatr Hematol Oncol 2006;28(11):703-10.